Cervical Cancer and Cervical Dysplasia: Symptoms, Diagnosis, Treatment & Complications

Cervical dysplasia is the presence of abnormal, precancerous cells on the cervix, almost always caused by long-lasting infection with a high-risk type of human papillomavirus (HPV). Cervical cancer is what can develop if those changes go undetected for years. Screening finds dysplasia early, when it's easy to treat, long before cancer forms.

The essentials: how HPV leads from dysplasia to cancer

HPV is the most common sexually transmitted infection, and almost every sexually active person encounters it at some point CDC. People blur an important distinction: the low-risk types (6 and 11) cause genital warts, while a separate set of high-risk types (16, 18, and others) cause cancer. The types that cause warts do not cause cancer, and vice versa. If you're worried about warts specifically, that's a different question, see genital warts symptoms.

In most cases the body clears HPV on its own. About nine out of ten infections resolve within two years without causing any health problems. Cervical cancer comes from the small fraction of high-risk infections that persist, when the virus settles into the cervical cells and, over many years, drives them to grow abnormally. That slow process gives a long window to catch and remove abnormal cells before they ever become cancer.

Cervical dysplasia is graded by how deep and abnormal the cell changes are. Low-grade changes often regress on their own as the infection clears. High-grade changes, meaning a larger portion of the surface layer is abnormal, are the ones treated, because they're the precursors to invasive cancer. HPV's cancer toll reaches well beyond the cervix: it causes virtually all cervical cancer, over 90% of anal cancers, and about 70% of throat (oropharyngeal) cancers. Oropharyngeal cancer has now overtaken cervical as the most common HPV-related cancer in the US NCI.

Symptoms: why early dysplasia feels like nothing

High-risk HPV is typically silent. The infection itself produces no symptoms, and early cervical dysplasia produces none either: no discharge, no pain, no lump you can feel. Paying closer attention won't change that. That's why cervical cancer is screened for rather than waited for. By the time symptoms appear, the disease has usually progressed.

When symptoms of advanced disease do show up, they can include:

• Abnormal vaginal bleeding: between periods, after sex, or after menopause.
• Bleeding or spotting after intercourse, which reflects a fragile, abnormal cervical surface.
• Unusual vaginal discharge that may be watery, bloody, or have an odor.
• Pelvic pain or pain during sex, which tends to appear later in the disease course.

None of these is unique to cancer, they overlap with infections, fibroids, and hormonal changes, but any of them warrants a clinician visit rather than a wait-and-see. Don't use symptoms as your screening tool. Screening lets you act while you feel completely well.

Testing: screening, not a symptom check

For women, HPV isn't found on a general STD panel; it's found through cervical screening. Current guidance now starts cervical screening at age 25 with a primary HPV test every five years as the preferred approach, rather than a yearly Pap American Cancer Society. Because most HPV clears on its own within two years, frequent testing catches transient infections that would have resolved anyway, while HPV-based testing catches more real precancer with fewer office visits.

Two related tests are used. A Pap test (cytology) collects cervical cells and a lab looks for abnormal ones. An HPV test checks the same kind of sample for the high-risk viral types themselves. Both involve a speculum exam and a quick swab, uncomfortable for a moment and over in minutes. If results are abnormal, the next step is usually a colposcopy, where a clinician examines the cervix under magnification and may take a small biopsy to grade any dysplasia precisely.

A few things screening is not. HPV tests are not recommended to screen men, adolescents, or women under age 30 CDC. There's no routine HPV test for men because no validated screening improves outcomes for them, which is also why a partner can't simply "get tested for HPV" the way they would for chlamydia. And HPV testing is not used to diagnose warts; the result doesn't confirm or guide wart management.

On anal screening: CDC's 2021 guidance found the data insufficient to recommend routine anal cytology, even for men who have sex with men or people with HIV. That position predates the 2022 ANCHOR trial, which showed that treating anal high-grade lesions reduced anal cancer in people with HIV; some specialty groups now suggest periodic anal Pap for high-risk people where high-resolution anoscopy referral exists. It's not a blanket CDC recommendation, so discuss your individual risk with a clinician.

At-home options exist for collecting an HPV sample, see at-home HPV test kits, and if you're sorting out timing after a new exposure, here's when to test after exposure. To start the process, you can get tested.

Treatment: removing dysplasia, and why warts are a separate problem

There's no antiviral that cures HPV itself. Treatment targets what the virus has caused. For cervical dysplasia, the goal is to remove or destroy the abnormal cells before they progress. Low-grade changes are often simply monitored, since many regress on their own as the infection clears. High-grade dysplasia is treated, typically with one of these office or outpatient procedures:

• Excision procedures, which cut out the abnormal tissue and send it to a lab for examination.
• Ablation, which destroys the abnormal cells with heat or cold.
• A small in-clinic procedure under local anesthetic in most cases, after which follow-up screening confirms the changes are gone.

Treating dysplasia is highly effective, and where screening is routine, cervical cancer death rates have fallen sharply because of it. Cancer precursors are managed separately from genital warts: wart therapy does nothing for dysplasia, and dysplasia treatment does nothing for warts.

Genital warts, caused by the low-risk types, are treated either at home or in the clinic, but never both for the same lesion at once. A clinic freezes them or you apply a prescription cream over weeks, none is clearly best, and because treatment doesn't remove the virus, warts can recur.

Prevention: the vaccine and screening together

The single most powerful prevention tool is the HPV vaccine. Given at the recommended ages, it can prevent more than 90% of HPV-caused cancers, and Gardasil 9 is about 98% effective against the precancers caused by HPV types 16 and 18 American Cancer Society. The vaccine used in the US today is Gardasil 9, which protects against nine types: 6, 11, 16, 18, 31, 33, 45, 52, and 58. Types 16 and 18 alone cause about 66% of cervical cancers, the five added high-risk types cause about another 15%, and types 6 and 11 cause more than 90% of genital warts.

The vaccine prevents infection; it doesn't treat one. Gardasil 9 protects against future infection but won't clear an infection or warts you already have, and vaccinated people still need cervical screening, because no vaccine covers every cancer-causing type. Vaccination matters for everyone, not just girls; here's HPV vaccine for boys.

Condoms give partial protection only, because HPV can infect skin a condom doesn't cover. Vaccination, routine screening, and condoms each close a gap the others can't.

When to see a clinician

Book a visit if you're due for cervical screening, if you've never been screened, or if you have any abnormal bleeding, between periods, after sex, or after menopause, or unusual discharge or pelvic pain. Don't wait for symptoms to decide whether to screen; act while you feel fine. If a screening result comes back abnormal, follow through on the colposcopy or repeat testing your clinician recommends. That follow-up is what turns an abnormal result into a problem solved.

Keep exploring on EasySTD: which STD test you need, STD incubation periods and HPV testing.